BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6179714)

  • 41. Use of a highly sensitive and specific immunoradiometric assay for detection of human chorionic gonadotropin in urine of normal, nonpregnant, and pregnant individuals.
    Armstrong EG; Ehrlich PH; Birken S; Schlatterer JP; Siris E; Hembree WC; Canfield RE
    J Clin Endocrinol Metab; 1984 Nov; 59(5):867-74. PubMed ID: 6480810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and characterization of antibodies to the urinary fragment of the human chorionic gonadotropin beta-subunit.
    Krichevsky A; Armstrong EG; Schlatterer J; Birken S; O'Connor J; Bikel K; Silverberg S; Lustbader JW; Canfield RE
    Endocrinology; 1988 Jul; 123(1):584-93. PubMed ID: 2454812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The follow-up of trophoblastic disease by using an hCG-CTP enzyme immunoassay].
    Matsuura Y; Kashimura M; Shinohara M; Baba S; Kondo M; Kashimura Y
    Gan No Rinsho; 1990 Dec; 36(15):2559-62. PubMed ID: 2176247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant beta-hCG.
    Dericks-Tan J; Taubert HD
    Fertil Steril; 1984 Mar; 41(3):488-9. PubMed ID: 6199235
    [No Abstract]   [Full Text] [Related]  

  • 45. Disparity between beta-core levels in pregnancy urine and serum: implications for the origin of urinary beta-core.
    Wehmann RE; Blithe DL; Akar AH; Nisula BC
    J Clin Endocrinol Metab; 1990 Feb; 70(2):371-8. PubMed ID: 1688864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
    Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
    Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A sensitive hemagglutination assay of human chorionic gonadotropin in the diagnosis of ectopic pregnancy.
    Hutchins CJ
    Obstet Gynecol; 1978 Oct; 52(4):499-502. PubMed ID: 714335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability of immunoreactive beta-core fragment of hCG.
    de Medeiros SF; Amato F; Norman RJ
    Obstet Gynecol; 1991 Jan; 77(1):53-9. PubMed ID: 1984227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A rapid direct latex agglutination test for HCG (author's transl)].
    Spona J
    Wien Klin Wochenschr; 1976 Apr; 88(9):289-91. PubMed ID: 973387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of methods for the prospective identification of early fetal losses in environmental epidemiology studies.
    Sweeney AM; Meyer MR; Aarons JH; Mills JL; LaPorte RE
    Am J Epidemiol; 1988 Apr; 127(4):843-50. PubMed ID: 3354549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An improved latex agglutination-inhibition test for the detection of human chorionic gonadotropin in urine.
    Lim PL; Choy WF
    J Immunol Methods; 1989 Feb; 117(1):137-9. PubMed ID: 2913159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of radioimmunoassays using mono- and polyclonal antibodies for the quantitation of human chorionic gonadotropin in early pregnancy.
    Heip J; Liu Y; Devroey P; Naaktgeboren N; Van Steirteghem AC
    Ann Biol Clin (Paris); 1986; 44(2):131-8. PubMed ID: 3752628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of four slide test kits for the detection of human chorionic gonadotropin in urine.
    Dietrich M; French JA
    Can Med Assoc J; 1974 Aug; 111(3):235-7. PubMed ID: 4851924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human chorionic gonadotrophin-like and beta-core-like materials in postmenopausal urine.
    Akar AH; Gervasi G; Blacker C; Wehmann RE; Blithe DL; Nisula BC
    J Endocrinol; 1990 Jun; 125(3):477-84. PubMed ID: 1695664
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
    Milhorn D; Korpi-Steiner N
    Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparative evaluation of ELISA and latex agglutination tests for detection of human chorionic gonadotropin (hCG) in urine for pregnancy.
    Ambedkar SS; Deshpande BS; Naik SR
    Hindustan Antibiot Bull; 1988; 30(1-2):12-5. PubMed ID: 3170256
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient extraction and sensitive radioimmunoassay for hCG in human urine.
    Shimizu T; Matsuura S; Mochizuki M
    Arch Gynecol; 1984; 234(4):247-54. PubMed ID: 6476895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A gonadotropin and alpha-subunit suppression test for the assessment of the ectopic production of human chorionic gonadotropin and its subunits after the menopause.
    Papapetrou PD; Anagnostopoulos NI
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1187-95. PubMed ID: 3923023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Emergency urinary HCG testing with the Tandem ICON.
    Macchione GJ; Cembrowski GS; McIntire TD; Knee GR; Strauss JF; Jacobsen S
    Clin Chem; 1985 Aug; 31(8):1405. PubMed ID: 3893801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.